For Eye Diseases

Introduction to Eye Diseases

Eye diseases include a wide range of conditions that may affect various parts of the eye and impair vision. According to medical records, around two to three million Americans aged 40-60 years and older are either legally blind or have low vision. These diseases can have various causes, including genetics, aging, infections, injuries, and systemic conditions like diabetes. Common eye diseases include the following:

• Age-related macular degeneration
• Bulging eyes
• Glaucoma
• Lazy eye
• Others

Oligonucleotide Therapeutics for Eye Diseases

Recently, the treatment of eye diseases with oligonucleotide therapeutics has attracted wide attention in the medical field. For example, antisense oligonucleotides (ASOs) were initially approved for treating cytomegalovirus retinitis, and they are currently being investigated as a treatment modality for many eye diseases, including inherited retinal disorders (IRD), inflammatory response and wound healing after glaucoma surgery, and macular degeneration^[1]. Oligonucleotides offer new ideas for the treatment of many eye diseases and are expected to benefit mankind in the future.

We are Developing Products for Eye Diseases

Alfa Chemistry specializes in human eye health. We are developing oligonucleotide therapeutics for the treatment of eye diseases, and the following are a few examples of our products in development. If you are also interested in oligonucleotide therapeutics and the related technology and services, please feel free to contact us and we will be happy to explore the potential of oligonucleotides in the treatment of eye diseases with you.

Note: NAION means non-arteritic anterior lschemic optic neuropathy.

Our products and services are for research use only and cannot be used for any clinical purposes.

Online Inquiry

* Name

Phone

* Email

* Services & Products of Interest For Eye Diseases

Project Description

* Verification Code

Submit